Moleculin Biotech, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $8.9M | $4.3M | $23.6M | $43.1M | $70.9M | $15.2M | $10.7M | $7.1M |
| Accounts Receivable | — | — | — | — | — | — | $1.0K | $56.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $9.7M | $5.2M | $26.3M | $45.6M | $72.5M | $17.2M | $13.5M | $8.0M |
| Property, Plant & Equipment | $78.0K | $159.0K | $272.0K | $275.0K | $338.0K | $483.0K | $316.0K | $463.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $22.1M | $16.9M | $38.2M | $57.4M | $84.1M | $29.0M | $25.2M | $19.6M |
| Liabilities | ||||||||
| Accounts Payable | $3.5M | $2.0M | $2.5M | $2.1M | $1.4M | $1.1M | $2.2M | $1.2M |
| Total Current Liabilities | $6.9M | $5.4M | $6.8M | $4.8M | $3.6M | $2.9M | $3.6M | $3.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.1M | $5.7M | $12.1M | $5.2M | $5.1M | $11.3M | $9.7M | $5.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-206.0M | $-172.4M | $-131.6M | $-101.8M | $-72.8M | $-56.9M | $-39.6M | $-26.4M |
| Total Stockholders' Equity | $15.0M | $11.2M | $30.9M | $52.2M | $79.0M | $17.8M | $15.6M | $14.3M |